Dosimetric Comparison of Volumetric Modulated Arc Therapy (VMAT), 5F Intensity Modulated Radiotherapy (IMRT) and 3D Conformal Radiotherapy (3DCRT) in Rectal Carcinoma Receiving Neoadjuvant Chemoradiotherapy

Ge Wen^1,2, Jinshan Zhang², Feng Chi¹, Li Chen¹, Sijuan Huang¹, Shaoqing Niu¹, Yuanhong Gao¹, Bixiu Wen^3*, Yujing Zhang^1*

¹Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
²Department of Radiation Oncology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
³Department of Radiation Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

DOI: 10.4236/ijmpcero.2015.41008                

Abstract

Objective: To investigate better dosimetric distribution of volumetric modulated arc therapy (VMAT) vs. 5F intensity modulated radiotherapy (IMRT) and 3D conformal radiotherapy (3DCRT) in patients with locally advanced rectal cancer (LARC) when treated with neoadjuvant chemoradiotherapy. Methods: 3D-CRT, 5F-IMRT and VMAT plans for preoperative radiotherapy were 66011designed in 12 patients with locally advanced rectal cancer. The conformity index (CI) and homogeneity index (HI) in target volume, and the dose and volume of the organs at risk (OAR) irradiated including small bowel, bladder and bilatera1 femoral heads were compared among the three plans. Results: The CI for planning target volume (PTV) 2 and HI for PTV1 of VMRT and 5F-IMRT were superior to 3D-CRT. The CI of VMAT, 5F-IMRT and 3D-CRT plans were 0.71, 0.69 and 0.62 (p = 0.011 and p = 0.019, respectively). The HI of the VMAT and 5F-IMRT plans were both 1.04 and 3D-CRT planning was 1.06 (p = 0.022 and p = 0.006, respectively). The V35 - V45 of small bowel in VMAT were significantly less than in 5F-IMRT and 3D-CRT. V35 was 47.0, 56.4, and 72.8 cm3 for VMAT, 5F-IMRT, and 3D-CRT (p = 0.021 and p = 0.034, respectively), while V40 was 30.5, 35.5, 45.1 cm3 (p = 0.024 and p = 0.032, respectively) and V45 was 15.1, 18.1, 30.0 cm3 (p = 0.033 and p = 0.032, respectively). The D5, V30 and V50 of bladder in 3D-CRT were less than in VMAT and 5F-IMRT planning (p = 0.034, 0.004, 0.002 and p = 0.027, 0.003, 0.002, respectively). The Dmean of left femoral head in VMAT and 5F-IMRT were less than in 3D-CRT planning (p = 0.028 and p = 0.022, respectively) and the Dmean, V30 of right femoral head in VMAT and 5F-IMRT were better than in 3D-CRT planning (p = 0.044, 0.036 and p = 0.023, 0.028, respectively). Conclusions: Dosimetric analyses demonstrated that IMRT is superior to 3D-CRT in the conformity and homogeneity of dose distribution to the target volume, and provide a better protection to OARs sparing in patients with locally advanced rectal cancer for preoperative radiotherapy. With similar target coverage, VMRT is superior to 5F-IMRT in normal tissue sparing.

Keywords

Rectal Cancer, Preoperative Radiotherapy, Dosimetry, Conformity Index, Homogeneity Index

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E. and Forman, D. (2011) Global Cancer Statistics. CA: A Cancer Journal for Clinicians, 61, 69-90. http://dx.doi.org/10.3322/caac.20107
[2]	Sauer, R., Becker, H., Hohenberger, W., Rodel, C., Wittekind, C., Fietkau, R., et al. (2004) Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer. The New England Journal of Medicine, 351, 1731-1740. http://www.nejm.org/doi/pdf/10.1056/NEJMoa040694 http://dx.doi.org/10.1056/NEJMoa040694
[3]	Bosset, J.F., Collette, L., Calais, G., Mineur, L., Maingon, P., Radosevic-Jelic, L., et al. (2006) Chemotherapy with Preoperative Radiotherapy in Rectal Cancer. The New England Journal of Medicine, 355, 1114-1123. http://www.nejm.org/doi/pdf/10.1056/NEJMoa060829 http://dx.doi.org/10.1056/NEJMoa060829
[4]	Sauer, R., Liersch, T., Merkel, S., Fietkau, R., Hohenberger, W., Hess, C., et al. (2012) Preoperative versus Postoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Results of the German CAO/ARO/AIO-94 Randomized Phase III Trial after A Median Follow up of 11 Years. Journal of Clinical Oncology, 30, 1926-1933. http://dx.doi.org/10.1200/JCO.2011.40.1836
[5]	Kilic, D., Yalman, D., Aksu, G., Atasoy, B.M., Igdem, S., Dincbas, F.O. and Yalcin, S. (2012) Impact of Adjuvant Chemoradiotherapy for Rectal Cancer on the Long-Term Quality of Life and Late Side Effects: A Multicentric Clinical Evaluation by the Turkish Oncology Group. Asian Pacific Journal of Cancer Prevention, 13, 5741-5746. http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No11/5741-46%2010.25%20Diclehan%20Kilic.pdf http://dx.doi.org/10.7314/APJCP.2012.13.11.5741
[6]	Robertson, J.M., Lockman, D., Yan, D., and Wallace, M. (2008) The Dose-Volume Relationship of Small Bowel Irradiation and Acute Grade 3 Diarrhea During Chemoradiotherapy for Rectal Cancer. International Journal of Radiation Oncology Biology Physics, 70, 413-418. http://dx.doi.org/10.1016/j.ijrobp.2007.06.066
[7]	Myerson, R.J., Garofalo, M.C., El Naqa, I., Abrams, R.A., Apte, A., Bosch, W.R., et al. (2009) Elective Clinical Target Volumes for Conformal Therapy in Anorectal Cancer: A Radiation Therapy Oncology Group Consensus Panel Contouring Atlas. International Journal of Radiation Oncology Biology Physics, 74, 824-830. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2709288/pdf/nihms121642.pdf http://dx.doi.org/10.1016/j.ijrobp.2008.08.070
[8]	van’t Riet, A., Mak, A.C., Moerland, M.A., Elders, L.H. and van der Zee, W. (1997) A Conformation Number to Quantify the Degree of Conformality in Brachytherapy and External Beam Irradiation: Application to the Prostate. International Journal of Radiation Oncology Biology Physics, 37, 731-736. http://dx.doi.org/10.1016/S0360-3016(96)00601-3
[9]	Liu, H.H., Wang, X., Dong, L., Wu, Q., Liao, Z., Stevens, C.W., et al. (2004) Feasibility of Sparing Lung and Other Thoracic Structures with Intensity-Modulated Radiotherapy for Non-Small-Cell Lung Cancer. International Journal of Radiation Oncology Biology Physics, 58, 1268-1279. http://dx.doi.org/10.1016/j.ijrobp.2003.09.085
[10]	Otto, K. (2008) Volumetric Modulated Arc Therapy: IMRT in a Single Gantry Arc. Medical Physics, 35, 310-317. http://dx.doi.org/10.1118/1.2818738
[11]	Cozzi, L., Dinshaw, K.A., Shrivastava, S.K., Mahantshetty, U., Engineer, R., Deshpande, D.D., et al. (2008) A Treatment Planning Study Comparing Volumetric Arc Modulation with Rapid Arc and Fixed Field IMRT for Cervix Uteri Radiotherapy. Radiotherapy & Oncology, 89, 180-191. http://www.thegreenjournal.com/article/S0167-8140(08)00338-1/pdf http://dx.doi.org/10.1016/j.radonc.2008.06.013
[12]	Wolff, D., Stieler, F., Welzel, G., Lorenz, F., Abo-Madyan, Y., Mai, S., et al. (2009) Volumetric Modulated Arc Therapy (VMAT) vs. Serial Tomotherapy, Step-and-Shoot IMRT and 3D-Conformal RT for Treatment of Prostate Cancer. Radiotherapy & Oncology, 93, 226-233. http://www.thegreenjournal.com/article/S0167-8140(09)00447-2/pdf http://dx.doi.org/10.1016/j.radonc.2009.08.011
[13]	Vieillot, S., Azria, D., Lemanski, C., Moscardo, C.L., Gourgou, S., Dubois, J.B., Ailleres, N. and Fenoglietto, P. (2010) Plan Comparison of Volumetric-Modulated Arc Therapy (RapidArc) and Conventional Intensity-Modulated Radiation Therapy (IMRT) in Anal Canal Cancer. Radiotherapy & Oncology, 5, 92. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2965153/pdf/1748-717X-5-92.pdf http://dx.doi.org/10.1186/1748-717X-5-92
[14]	Arbea, L., Ramos, L.I., Martinez-Monge, R., Moreno, M. and Aristu, J. (2010) Intensity-Modulated Radiation Therapy (IMRT) vs. 3D Conformal Radiotherapy (3DCRT) in Locally Advanced Rectal Cancer (LARC): Dosimetric Comparison and Clinical Implications. Radiation Oncology, 5, 17. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845593/pdf/1748-717X-5-17.pdf http://dx.doi.org/10.1186/1748-717X-5-17
[15]	Cilla, S., Caravatta, L., Picardi, V., Sabatino, D., Macchia, G., Digesu, C., et al. (2012) Volumetric Modulated Arc Therapy with Simultaneous Integrated Boost for Locally Advanced Rectal Cancer. Clinical Oncology, 24, 261-268. http://dx.doi.org/10.1016/j.clon.2011.07.001
[16]	Natrah, M.S., Ezat, S., Syed, M.A., Rizal, A.M. and Saperi, S. (2012) Quality of Life in Malaysian Colorecatl Cancer Patients: A Preliminary Result. Asian Pacific Journal of Cancer Prevention, 13, 957-962. http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No3/957-62%201.29%20Natra.pdf http://dx.doi.org/10.7314/APJCP.2012.13.3.957
[17]	Gunnlaugsson, A., Kjellen, E., Nilsson, P., Bendahl, P.O., Willner, J. and Johnsson, A. (2007) Dose-Volume Relationships Between Enteritis and Irradiated Bowel Volumes During 5-Fluorouracil and Oxaliplatin Based Chemoradiotherapy in Locally Advanced Rectal Cancer. Acta Oncologica, 46, 937-944. http://informahealthcare.com/doi/pdf/10.1080/02841860701317873 http://dx.doi.org/10.1080/02841860701317873
[18]	Devisetty, K., Mell, L.K., Salama, J.K., Schomas, D.A., Miller, R.C., Jani, A.B., et al. (2009) A Multi-Institutional Acute Gastrointestinal Toxicity Analysis of Anal Cancer Patients Treated with Concurrent Intensity-Modulated Radiation Therapy (IMRT) and Chemotherapy. Radiotherapy & Oncology, 93, 298-301. http://dx.doi.org/10.1016/j.radonc.2009.07.006
[19]	Samuelian, J.M., Callister, M.D., Ashman, J.B., Young-Fadok, T.M., Borad, M.J. and Gunderson, L.L. (2012) Reduced Acute Bowel Toxicity in Patients Treated with Intensity-Modulated Radiotherapy for Rectal Cancer. International Journal of Radiation Oncology Biology Physics, 82, 1981-1987. http://dx.doi.org/10.1016/j.ijrobp.2011.01.051
[20]	Cranmer-Sargison, G., Kundapur, V., Park-Somers, E., Andreas, J., Vachhrajani, H. and Sidhu, N.P. (2013) Planning Target Volume Margin Evaluation and Critical Structure Sparing for Rectal Cancer Patients Treated Prone on A Bellyboard. Clinical Oncology, 25, e17-e22.
[21]	Kry, S.F., Salehpour, M., Followill, D.S., Stovall, M., Kuban, D.A., White, R.A. and Rosen, I.I. (2005) Out-of-Field Photon and Neutron Dose Equivalents from Step-and-Shoot Intensity-Modulated Radiation Therapy. International Journal of Radiation Oncology Biology Physics, 62, 1204-1216. http://www.redjournal.org/article/S0360-3016(05)00599-7/abstract
[22]	Emami, B., Lyman, J., Brown, A., Coia, L., Goitein, M., Munzenrider, J.E., et al. (1991) Tolerance of Normal Tissue to Therapeutic Irradiation. International Journal of Radiation Oncology Biology Physics, 21, 109-122. http://dx.doi.org/10.1016/0360-3016(91)90171-Y
[23]	Zelefsky, M.J., Fuks, Z., Hunt, M., Yamada, Y., Marion, C., Ling, C.C., et al. (2002) High-Dose Intensity Modulated Radiation Therapy for Prostate Cancer: Early Toxicity and Biochemical Outcome in 772 Patients. International Journal of Radiation Oncology Biology Physics, 53, 1111-1116. http://dx.doi.org/10.1016/S0360-3016(02)02857-2